Are you Dr. Lieberman?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 31 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
6565 Fannin Street
MS205
Houston, TX 77030Phone+1 713-394-6450Fax+1 713-793-1603
Summary
- Dr. Michael Lieberman, MD is a board certified pathologist in Houston, Texas. He is currently licensed to practice medicine in Texas. He is affiliated with Houston Methodist Hospital.
Education & Training
UPMC Medical EducationResidency, Pathology-Anatomic and Clinical, 1967 - 1969
University of Pittsburgh School of MedicineClass of 1967
Certifications & Licensure
TX State Medical License 1989 - 2014- American Board of Pathology Anatomic Pathology
Publications & Presentations
PubMed
- 230 citationsThe MRP2/cMOAT Transporter and Arsenic-Glutathione Complex Formation Are Required for Biliary Excretion of ArsenicSubbarao V. Kala, Matthew W. Neely, Geeta Kala, Christopher I. Prater, Donna W. Atwood
The Journal of Biological Chemistry. 2000-10-27 - 77 citationsFormation and Urinary Excretion of Arsenic Triglutathione and Methylarsenic DiglutathioneSubbarao V. Kala, Geeta Kala, Christopher I. Prater, and Alan C. Sartorelli, Michael W. Lieberman
Chemical Research in Toxicology. 2004-02-01 - 55 citationsN-acetylcysteine as an antidote in methylmercury poisoning.Nazzareno Ballatori, Michael W. Lieberman, Wei Wang
Environmental Health Perspectives. 1998-05-01
Grant Support
- As-Gsh Conjugation Limits As Availability &ToxicityNational Institute Of Environmental Health Sciences2000–2004
- Baylor College Of Medicine Cancer CenterNational Cancer Institute2003
- Function Of Gamma Glutamyl LeukotrienaseNational Institute Of Environmental Health Sciences2001–2003
- Response To Injury In Gammaglutamyl Cycle Deficient MiceNational Institute Of Environmental Health Sciences2000–2003
- Metabolism In Gamma-Glutamy1 Transpeptidase Defict MiceNational Institute Of Environmental Health Sciences1997–2000
- Responses To Injury In Gamma Glutamyl Cycle DeficientNational Institute Of Environmental Health Sciences1997–1999
- Metabolism In And-Glutamyl Transpeptidase Deficient MiceNational Institute Of Environmental Health Sciences1996
- Consequences Of Targetet Gene Expression To The ProstateNational Cancer Institute1992–1995
- Carcinogen Activation Of Unexpressed Mammalian GenesNational Cancer Institute1989–1995
- Carcinogen Activation Of Unexpressed GenesNational Cancer Institute1994
- Molecular Pathology Of Transgenic Liver &Kidney CancerNational Cancer Institute1991–1993
- Molecular Mechanisms Of Carcinogenesis ConferenceNational Cancer Institute1991
- Metallothionein Activation--A Model Of Carcinogen ActionNational Cancer Institute1989–1991
- Gene Expression In Carcinogen-Induced Liver CancerNational Cancer Institute1989–1990
- Analysis Of Hepatocellular Carcinoma Development By NMR ImagingNational Cancer Institute1987–1989
- Carcinogen Activation Of Unexpressed Mammalian GenesNational Cancer Institute1988
- Gene Expression In Carcinogen-Induced Liver CancerNational Cancer Institute1985–1988
- Carcinogen Activation Of Unexpressed Mammalian GenesNational Cancer Institute1985–1987
